MarginsXMarginsX
Home › Markets › Health Care › MDCX

Medicus Pharma Ltd. Common Stock (MDCX)

MDCX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.69
-13.33% on the day
Market cap
$3.2M
Nano cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerMDCX on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryCanada
IPO yearNot reported by the screener
SEC CIK0001997296
SEC industry codePharmaceutical Preparations
Incorporated inON

Financials

Foreign filer: no machine-readable annual figure in SEC data.

Warning signs

Cash runway
1.6 months
$5.0M cash at September 30, 2026
Share count, 1 year
+336.4%
2025-11-11 to 2026-11-02
Going-concern doubt
Yes
10-Q filed November 6, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"This uncertainty, together with the Company's continued losses and outstanding debt obligations, indicates that substantial doubt exists about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued."
10-Q 2026-11-06
Cash and burn$5.0M cash; operating cash flow -$9.6M a quarter.Report 2026-09-30
Shares outstanding1,922,837 (2026-11-02); 22,029,144 a year earlier. 1y figure adjusted for split (1-for-50 overall).Cover page 2026-11-02
Reverse splits, 3 years1; latest 1-for-50 on 2026-10-12Source 2026-10-12
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2026-01-02
Exchange deficiency notices, 12 months3 (8-K item 3.01)8-K 2026-10-23
AuditorKPMG LLP, New York, New York, United States; changed auditors 1 time in 24 months8-K 4.01 2025-06-05
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$15.2M-$15.9M$5.0MNo debt tagsNeeds four quarters10-Q 2026-11-06
Q2 2026
2026-06-30
Not filed-$11.6M-$7.0M$15.2MNo debt tagsNeeds four quarters10-Q 2026-08-12
Q1 2026
2026-03-31
Not filed-$9.0M-$9.0M$6.4M$2.3MNeeds four quarters10-Q 2026-05-14
Q4 2025
2025-12-31
Not filed-$15.1M-$6.6M$8.7M$5.2MNeeds four quarters10-K 2026-03-25
Q3 2025
2025-09-30
Not filed-$20.9M-$6.8M$8.7M$6.8MNeeds four quarters10-Q 2026-11-06
Q2 2025
2025-06-30
Not filed-$6.2M-$5.5M$9.7M$4.7MNeeds four quarters10-Q 2026-08-12
Q1 2025
2025-03-31
Not filed-$5.1M-$3.9M$4.0MNo debt tagsNeeds four quarters10-Q 2026-05-14
Q4 2024
2024-12-31
Not filed-$3.5M-$3.2M$4.2M$0Needs four quarters10-K 2026-03-25

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM 424B3
424B32026-11-16
Latest annual report
FORM 10-K/A
10-K/A2026-04-29
Latest quarterly / interim
FORM 10-Q
10-Q2026-11-06
Latest current report
FORM 8-K
8-K2026-11-16
Latest proxy
FORM DEF 14A
DEF 14A2026-10-30

Source: SEC EDGAR submissions feed, 350 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+4.3%
1 month-40.5%
3 months-89.0%
Year to date-97.5%
1 year-98.3%
From 52-week high-98.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
MDCXWMedicus Pharma Ltd. Warrant$0.2000

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
RDHLRedhill Biopharma Ltd.$0.3605-3.87%$3.2M
APUSApimeds Pharmaceuticals US Inc.$2.04-8.52%$3.1M
SILOSilo Pharma Inc.$1.57-14.40%$3.4M
GRIGRI Bio Inc.$1.40-18.60%$3.1M
XBIOXenetic Biosciences Inc.$1.49-10.24%$3.5M
MBIOMustang Bio Inc.$0.3947-6.34%$3.0M
NRSNNeuroSense Therapeutics Ltd.$1.56-7.40%$3.0M
DRMADermata Therapeutics Inc.$0.5985-3.65%$3.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier